S'abonner

Assisted reproductive technology and neurodevelopment in children at 1 year of age: a longitudinal birth cohort study - 22/10/24

Doi : 10.1016/j.ajog.2024.05.039 
Weiting Wang, MPH a, b, Qingxia Meng, MD a, c, d, Lingmin Hu, MD, PhD a, e, Jiangbo Du, PhD a, d, f, Bo Xu, MPH a, f, Xiumei Han, MPH a, f, Xiaoyu Liu, MPH a, f, Kun Zhou, MPH a, f, Kang Ke, PhD a, f, Ming Gan, MPH a, f, Xianxian Zhu, MPH a, b, Yuting Peng, MPH a, b, Huixin Xue, MPH a, f, Shuxin Xiao, MPH a, b, Hong Lv, PhD a, d, f, Yangqian Jiang, PhD a, b, Tao Jiang, PhD a, g, Hongxia Ma, MD, PhD a, d, f, Xiufeng Ling, MD, PhD a, h, , Zhibin Hu, MD, PhD a, d, f, , Yuan Lin, MD, PhD a, b, d,
a State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, Jiangsu, China 
b Department of Maternal, Child and Adolescent Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China 
c Reproductive Genetic Center, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, China 
d State Key Laboratory of Reproductive Medicine and Offspring Health (Suzhou Centre), The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, China 
e Department of Reproduction, Changzhou Maternity and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu, China 
f Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China 
g Department of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China 
h Department of Reproduction, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, Jiangsu, China 

Corresponding authors: Yuan Lin, MD, PhD.∗∗Zhibin Hu, MD, PhD.∗∗∗Xiufeng Ling, MD, PhD.

Abstract

Background

With remarkable advancements in assisted reproductive technology (ART), the number of ART-conceived children continues to increase. Despite increased research investigating the outcomes of ART children, evidence on neurodevelopment remains controversial.

Objective

The aim of this study was to investigate the association between ART use and neurodevelopment in children at 1 year of age and to determine whether the characteristics of parental infertility and specific ART procedures affect neurodevelopment in children.

Study design

The Jiangsu Birth Cohort enrolled couples who received ART treatment and who conceived spontaneously (2014–2020) in Jiangsu Province, China. In this study, we included 3531 pregnancies with 3840 cohort children who completed neurodevelopment assessment at 1 year of age, including 1906 infants conceived by ART (including 621 twins). Poisson regressions were fitted to estimate unadjusted and adjusted risk ratios (RRs) and 95% confidence intervals (CIs) for ART use with neurodevelopmental outcomes (cognition, receptive communication, expressive communication, fine motor, and gross motor) in children.

Results

Among singletons, ART use was associated with a 24% to 34% decrease in the risk for noncompetent development in 3 domains (cognition, adjusted RR, 0.66; 95% CI, 0.53–0.82; receptive communication, 0.76; 0.64–0.91; expressive communication, 0.69; 0.51–0.93) after adjustment for conventional covariates. However, an inverse association was observed in the gross motor domain, with ART singletons having a greater risk of being noncompetent in gross motor development than their non-ART counterparts (adjusted RR, 1.41; 95% CI, 1.11–1.79). Compared with singletons, twins resulting from ART treatment demonstrated compromised neurodevelopment in several domains. Furthermore, we continued to observe that the transfer of ‘poor’ quality embryos was associated with greater risks for noncompetent development in receptive communication (adjusted RR, 1.50; 95% CI, 1.05–2.14) and gross motor domains (1.55; 1.02–2.36) among ART singletons.

Conclusion

These results generally provide reassuring evidence among singletons born after ART in the cognition, communication, and fine motor domains, but drawn attention to their gross motor development. The quality of transferred embryos in ART treatment might be associated with offspring neurodevelopment; however, the potential associations warrant further validation in independent studies, and the clinical significance needs careful interpretation.

Le texte complet de cet article est disponible en PDF.

Key words : assisted reproductive technology, birth cohort, embryo quality, neurodevelopment


Plan


 W.W., Q.M., L.H., and J.D. contributed equally to this study.
 The authors report no conflict of interest.
 This study was funded by the National Key Research and Development Program of China (grant number, 2021YFC2700600) and National Natural Science Foundation of China (grant number, 82221005). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
 Data Sharing Statement: After publication, the data collected for the study (deidentified participant data) could be accessed on reasonable request to the corresponding author. A proposal with detailed description of study objectives and statistical analysis plan will be needed for evaluation of the reasonability of requests. Additional, relevant documents might also be required during the process of evaluation.
 Cite this article as: Wang W, Meng Q, Hu L, et al. Assisted reproductive technology and neurodevelopment in children at 1 year of age: a longitudinal birth cohort study. Am J Obstet Gynecol 2024;231:532.e1-21.


© 2024  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 231 - N° 5

P. 532.e1-532.e21 - novembre 2024 Retour au numéro
Article précédent Article précédent
  • Placement of an intrauterine device within 48 hours after second-trimester medical abortion: a randomized controlled trial
  • Sara Hogmark, Johanna Rydelius, Niklas Envall, Pia Teleman, Kristina Gemzell-Danielsson, Helena Kopp Kallner
| Article suivant Article suivant
  • Management of breakthrough bleeding in transgender and gender diverse individuals on testosterone
  • Frances W. Grimstad, Elizabeth R. Boskey, Rachael S. Clark, Cecile A. Ferrando

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.